<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN" "JATS-archivearticle1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JPSIM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Pakistan Society of Internal Medicine</journal-title>
        <abbrev-title>J Pak Soc Intern Med</abbrev-title>
      </journal-title-group>
      <issn publication-format="print">2709-8729</issn>
      <issn publication-format="electronic">2710-0804</issn>
      <publisher>
        <publisher-name>Pakistan Society of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.70302/jpsim.v6i3.2544</article-id>
      <article-id pub-id-type="publisher-id">jpsim.v6i3.2544</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Prevalence of Adverse Donor Reactions among Healthy Blood Donors Presenting in a Tertiary Care Hospital Blood Bank</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ranjha</surname>
            <given-names>Irfan</given-names>
          </name>
          <email>irfanranjha43291@import.invalid</email>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chaudhary</surname>
            <given-names>Hammad Tufail</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Amin</surname>
            <given-names>Irfan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fateen</surname>
            <given-names>Tooba</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saeed</surname>
            <given-names>Muhammad</given-names>
          </name>
          <xref ref-type="aff" rid="aff3"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <institution>Allama Iqbal Medical College, Lahore, Pakistan</institution>
      </aff>
      <aff id="aff2">
        <institution>Taif University, Taif, Saudi Arabia</institution>
      </aff>
      <aff id="aff3">
        <institution>Kohsar University, Murree, Pakistan</institution>
      </aff>
      <author-notes>
        <corresp id="cor1">*Correspondence: Irfan Ranjha (irfanranjha43291@import.invalid)</corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic" iso-8601-date="2025-08-23">
        <day>23</day>
        <month>08</month>
        <year>2025</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2025</year>
      </pub-date>
      <volume>6</volume>
      <issue>3</issue>
      <fpage>239</fpage>
      <lpage>244</lpage>
      <history>
        <date date-type="received" iso-8601-date="2025-02-14">
          <day>14</day>
          <month>02</month>
          <year>2025</year>
        </date>
        <date date-type="rev-recd" iso-8601-date="2025-02-25">
          <day>25</day>
          <month>02</month>
          <year>2025</year>
        </date>
        <date date-type="accepted" iso-8601-date="2025-07-28">
          <day>28</day>
          <month>07</month>
          <year>2025</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2025 The Author(s)</copyright-statement>
        <copyright-year>2025</copyright-year>
        <copyright-holder>The Author(s)</copyright-holder>
        <ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v6i3.2544" content-type="text/html"/>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v6i3.2544.pdf" content-type="application/pdf"/>
      <abstract>
        <sec>
          <title>Objectives</title>
          <p>To determine the incidence and types of adverse donor reactions among healthy blood donors during the blood donation process.</p>
        </sec>
        <sec>
          <title>Methodology</title>
          <p>In this descriptive cross-sectional study, which was carried out at Blood Bank Jinnah Hospital, Lahore, over a period of six months from Aug 2023 to Jan 2024, a total of 550 healthy blood donors aged 18-60 years fulfilling the donation criteria were enrolled. After the informed consent, the study participants were observed during the whole donation process. Collected data were analyzed using SPSS software.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Data from 550 donors consisting of 543 males and 7 females revealed mean age, height and weight of 28 years, 167 cm and 71 kg respectively. 484 (88%) were Rh positive blood groups and 66 (12%) were Rh negative groups. 28 (5.1%) donors experienced some adverse reactions and all were males. 8 (28%) of 28 were donating for the first time. All the reactions were mild to moderate in nature and no medical emergency or life- threatening situation appeared. 8 (28%) had slow pulse and fall in BP, 5 (18%) had nausea, 3 (10%) fainted, 3 (10%) were double pricked, 2 (7%) experienced warmth and head sweating, 2 (7%) had cold extremities, 2 (7%) had pain at the local site, 1 (4%) vomited, 1 (4%) felt fatigue, and 1 (4%) developed a hematoma.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Blood donation is a safe and risk-free procedure as only a few donors have experienced mild to moderate reactions. Proper training of blood bank staff and counselling of blood donors can reduce these adverse events more effectively.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en" kwd-group-type="author-keywords">
        <title>Keywords</title>
        <kwd>Blood Donation</kwd>
        <kwd>Blood Donor</kwd>
        <kwd>Adverse reactions</kwd>
        <kwd>Blood bank</kwd>
        <kwd>Tertiary care hospital</kwd>
        <kwd>Lahore.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <!-- <body> omitted: no manuscript (.docx) on file -->
  <back>
    <notes notes-type="ethics-statement">
      <title>Ethics Statement</title>
      <p>Ethics committee: Institutional Review Board / Ethics Committee (IRB/EC). Approval number: ERB150/3/14-09-2023/S1, dated September 14, 2023.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation>Roberts N, James S, Delaney M, Fitzmaurice C. The global need and availability of blood products: a modelling study. Lancet Haematol. 2019;6(12):e606-e15.</mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation>Custer B, Rios JA, Schlumpf K, Kakaiya RM, Gottschall JL, Wright DJ, et al. Adverse reactions and other factors that impact subsequent blood donation visits. Transfusion. 2012;52(1):118-26.</mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation>Shabber HI, Ishtiaq M, Waheed U, Zaheer HA. Adverse Reactions in Blood Donors in a Tertiary Care Teaching Hospital Blood Bank of Islamabad, Pakistan. J Islamabad Med Dental Coll. 2016;5(2):81-3.</mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation>Kujur P, Tiwari AK, Bagde S, Bombeshwar V, Behera TR. Assessment of blood donor selection and deferral pattern in a tertiary care hospital in Central India. Trop J Pathol Microbiol. 2020;6(1):83.</mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation>Malhotra S, Negi G. Analysis of reasons of blood donor deferral at a tertiary care institute in India and its reflections on community health status. Asian J Transf Sci. 2023;17(1):48-52.</mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation>Sultan S, Baig MA, Irfan SM, Ahmed SI, Hasan SF. Adverse reactions in allogeneic blood donors: A tertiary care experience from a developing country. Oman Med J. 2016;31(2):124.</mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation>Nchinda E, Tagny C, Mbanya D. Blood donor haemovigilance in Yaoundé, Cameroon. Transfusion Medicine. 2012;22(4):257-61.</mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation>John CA, Theodora UE, Gloria AN, Chika EA. Adverse reactions to blood donation: A descriptive study of 3520 blood donors in a Nigerian tertiary hospital. Med J of Dr DY Patil Vidyapeeth. 2017;10(1):36-40.</mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <mixed-citation>Philip J, Sarkar R, Jain N. A single-centre study of vasovagal reaction in blood donors: Influence of age, sex, donation status, weight, total blood volume and volume of blood collected. Asian J Transf Sci. 2014;8(1):43-6.</mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <mixed-citation>Young P, Crowder L, Steele W, Irving D, Pink J, Kutner JM, et al. Frequency of rare, serious donor reactions: international perspective. Transfusion. 2021;61(6):1780-8.</mixed-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <mixed-citation>Crocco I, Franchini M, Garozzo G, Gandini AR, Gandini G, Bonomo P, et al. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. Blood Transf. 2009;7(1):35.</mixed-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <mixed-citation>Barbosa MH, Silva KFNd, Coelho DQ, Tavares JL, Cruz LFd, Kanda MH. Risk factors associated with the occurrence of adverse events in plateletpheresis donation. Rev Brasil Hematol Hemot. 2014;36:191-5.</mixed-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <mixed-citation>Almutairi H, Salam M, Alajlan A, Wani F, Al-Shammari B, Al-Surimi K. Incidence, predictors and severity of adverse events among whole blood donors. PloS One. 2017;12(7):e0179831.</mixed-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <mixed-citation>Dogra A, Sidhu M, Dogra M, Raina TR. Study of adverse whole blood donor reactions in normal healthy blood donors: experience of tertiary health care centre in jammu region. Indian J Hemato Blood Transf. 2015;31(2):142-5.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
